Results 11 to 20 of about 24,471 (221)

Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma

open access: yesRare Tumors, 2015
We report a response to pazopanib in a 69-year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor.
Steven Attia   +12 more
doaj   +2 more sources

Immuno-stimulation by OX40 ligand transgenic Ewing sarcoma cells

open access: yesFrontiers in Oncology, 2015
Interleukin-2 (IL-2) transgenic Ewing sarcoma cells can induce tumor specific T and NK cell responses and reduce tumor growth in vivo and in vitro. Nevertheless, the efficiency of this stimulation is not high enough to inhibit tumor growth completely. In
Dajana eReuter   +3 more
doaj   +2 more sources

Cervical vertebra plana secondary to Ewing sarcoma: A case report [PDF]

open access: yesRadiology Case Reports
Vertebra plana is most commonly associated with Langerhans cell histiocytosis in the pediatric population. However, in extremely rare cases, Ewing sarcoma can also present as vertebra plana in this population. Langerhans cell histiocytosis can present as
Richie Zhang, BA   +4 more
doaj   +2 more sources

Ewing Sarcoma

open access: yesClinical Pediatric Hematology-Oncology, 2019
Ewing sarcoma is the second most frequently occurring malignant tumor of the bone and soft tissue in adolescents and young adults. Genetically, Ewing sarcoma is characterized by balanced chromosomal translocation in which a member of FET gene family is ...
Hee Young Ju
doaj   +2 more sources

Ewing’s Sarcoma [PDF]

open access: yesNew England Journal of Medicine, 2021
Ewing’s Sarcoma Ewing’s sarcoma, an aggressive cancer of bone and soft tissue, primarily affects children and young adults. A t(11;22) translocation is noted in 85 to 90% of cases.
Ludwig, Joseph A.   +2 more
openaire   +6 more sources

Ewing sarcoma [PDF]

open access: yesPediatric Blood & Cancer, 2021
AbstractEwing sarcoma is a rare tumor that requires complex multidisciplinary management. This report describes the general management and standard radiotherapy guidelines in both North America (Children's Oncology Group) and Europe (International Society of Pediatric Oncology).
Bree R. Eaton   +6 more
openaire   +2 more sources

High‐Dose Continuous Infusion Ifosfamide as Effective Palliation in a Patient With Relapsed Ewing Sarcoma With Bone Marrow Infiltration and Severe Thrombocytopenia: A Case Report [PDF]

open access: yesCancer Reports
Background Ewing sarcoma is a rare primary mesenchymal tumor of the bone that requires an intensive multimodal therapeutic approach. Multidrug chemotherapy regimens are also the backbone for relapsing/recurring Ewing sarcoma treatment, yet when the ...
Fabio Murtas   +11 more
doaj   +2 more sources

Caregivers Awareness Regarding Health Care offered to their children with Ewing Sarcoma [PDF]

open access: yesEgyptian Journal of Health Care, 2023
Background: Ewing sarcoma is a very aggressive malignancy tumor that requires complex multidisciplinary management. The aim of the study: Was to assess caregivers’ awareness regarding health care offered to their children with Ewing sarcoma.
Lamyaa Momtaz Mohamed   +2 more
doaj   +1 more source

CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells [PDF]

open access: yes, 2023
The chimeric EWSR1::FLI1 transcription factor is the main oncogenic event in Ewing sarcoma. Recently, it has been proposed that EWSR1::FLI1 levels can fluctuate in Ewing sarcoma cells, giving rise to two cell populations.
Luis Chapado   +23 more
core   +1 more source

Ewing Sarcoma Developed at the Site of Previous Mast Cell Proliferation [PDF]

open access: yes, 2023
KIT gene mutations in Ewing sarcomas are rare; however, they are much more frequent in other neoplasms, namely mastocytosis. We describe a case of an adult male with a one-year duration of recurrent episodes of pain, swelling, and redness on the proximal
Rosendo, Eugénia   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy